CSIMarket
 
Neuroone Medical Technologies Corp  (NASDAQ: NMTC)
 

Neuroone Medical Technologies's Customers Performance

NMTC



 
NMTC's Source of Revenues During the corresponding time, Neuroone Medical Technologies Corp recorded a revenue increase by 72.46 % year on year, sequentially revenue fell by -17.34 %. While revenue at the Neuroone Medical Technologies Corp's corporate clients

List of NMTC Customers




for the same period Neuroone Medical Technologies Corp recorded revenue increase by 72.46 % year on year, sequentially revenue fell by -17.34 %.

List of NMTC Customers

Neuroone Medical Technologies's Business Units






Neuroone Medical Technologies's Comment on Sales, Marketing and Customers



NeuroOne Medical Technologies Corporation serves approximately 188 Level 4 epilepsy centers through an exclusive global distribution agreement with Zimmer. Under this agreement, Zimmer holds exclusive rights to distribute NeuroOne's strip and grid cortical electrodes, electrode cable assembly products, certain depth electrodes (sEEG products), and the OneRF Ablation System. Zimmer is responsible for commercialization activities, including promotion, marketing, and sales, while NeuroOne manages development and regulatory approval. The agreement also encompasses manufacturing and supply arrangements and is set to expire on September 30, 2034, with provisions for termination under specified conditions.





Neuroone Medical Technologies’s Comment on Sales, Marketing and Customers


NeuroOne Medical Technologies Corporation serves approximately 188 Level 4 epilepsy centers through an exclusive global distribution agreement with Zimmer. Under this agreement, Zimmer holds exclusive rights to distribute NeuroOne's strip and grid cortical electrodes, electrode cable assembly products, certain depth electrodes (sEEG products), and the OneRF Ablation System. Zimmer is responsible for commercialization activities, including promotion, marketing, and sales, while NeuroOne manages development and regulatory approval. The agreement also encompasses manufacturing and supply arrangements and is set to expire on September 30, 2034, with provisions for termination under specified conditions.








NMTC's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neuroone Medical Technologies Corp 12.73 9.72 -6.64 18
SUBTOTAL 0.00 0.00 0.00 -

Sources: Neuroone Medical Technologies Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Neuroone Medical Technologies Corp’s corporate clients.
For your research, we’ve provided 9 tables on Neuroone Medical Technologies Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.